Developmental Core (Core B)

开发核心-项目总结 田纳西州艾滋病研究中心（CFAR）是一个研究密集型的四方合作伙伴关系， 机构（范德比尔特大学医学中心），一个历史上的黑人医学院（梅哈里医学院）， 一个学术参与的州卫生部（田纳西州卫生部），和一个复杂的 25年来专门关注艾滋病毒问题的社区组织（纳什维尔CARES）。发育 核心（DC）将支持和加强四个合作伙伴的跨学科艾滋病毒/艾滋病合作研究 机构职能体系在新的发展中心倡议和领导的推动下，发展中心将实现三个相辅相成的目标： 1)管理一个强大的CFAR DC奖计划，支持跨学科的艾滋病毒研究项目， 新的艾滋病毒研究试点项目; 2）确保对艾滋病毒研究新手的指导，重点是 早期阶段，少数民族，妇女和公共卫生调查员，以提高竞争力的校外资金， 3）促进学术技能发展和科学团队建设。在2019年，DC领导结构 过渡，与约翰Koethe，医学博士，MSCI，医学副教授在范德比尔特，承担的作用， DC主任，由Fernando Villalta博士和Tim Sterling医学博士作为副主任提供支持。该变化 为了响应广泛的战略规划，我们的CFAR外部和内部科学 咨询委员会，作为本年度财务报告即将到来的供资周期继任规划的一部分。DC不会 只为有前途的早期研究人员提供DC奖资金，但将继续确保 适当的指导以及促进团队建设的活动。这将有助于早期调查人员 认识到有效合作的至关重要性，因为他们发展成为有成就的学术 研究科学家。以艾滋病毒为重点的DC奖，指导和技能发展将与 范德比尔特出色的机构支持（通过范德比尔特临床和转化研究所 研究; VICTR）和Meharry（通过Meharry翻译研究中心; MeTRC和该中心） MMC的健康差异研究），以最大限度地发挥重要的，突破性的研究， 将导致校外资金支持，最终对艾滋病毒的负担产生重大影响， 田纳西州，全国，全世界。

Developmental Core – PROJECT SUMMARY The Tennessee Center for AIDS Research (CFAR) is a four-way partnership between a research-intensive institution (Vanderbilt University Medical Center), a historically black medical college (Meharry Medical College), an academically-engaged state health department (Tennessee Department of Health), and a sophisticated community-based organization with a 25-year exclusive focus on HIV (Nashville CARES). The Developmental Core (DC) will support and enhance collaborative, interdisciplinary HIV/AIDS research at the four partner institutions. Invigorated by new DC initiatives and leadership, the DC will pursue three complementary objectives: 1) To administer a robust CFAR DC Awards program that supports interdisciplinary HIV research projects and new HIV research pilot projects; 2) To ensure mentoring of investigators new to HIV research, with a focus on early stage, minority, women, and public health investigators, to enhance competitiveness for extramural funding, and; 3) To foster academic skills development and scientific team-building. In 2019, the DC leadership structure transitioned, with John Koethe, MD, MSCI, Associate Professor of Medicine at Vanderbilt, assuming the role of DC Director, supported by Fernando Villalta, PhD and Tim Sterling, MD as Associate Directors. This change was in response to extensive strategic planning, with input from the our CFAR External and Internal Scientific Advisory Boards, as part of succession planning for the upcoming funding cycle of this CFAR. The DC will not only provide DC Award funding for promising early-stage investigators but will continue to assure that there is appropriate mentoring together with activities to foster team building. This will help early-stage investigators appreciate the critical importance of effective collaboration as they develop into accomplished academic research scientists. The HIV-focused DC Awards, mentoring, and skills development will be leveraged with outstanding institutional support at Vanderbilt (through the Vanderbilt Institute for Clinical and Translational Research; VICTR) and at Meharry (through the Meharry Translational Research Center; MeTRC, and the Center for Health Disparities Research at MMC) to maximize the potential for important, ground-breaking research that will lead to extramural funding support, and that ultimately has substantial impact on the burden of HIV in Tennessee, the nation, and worldwide.